Alchemab, Therapeutics Alchemab Therapeutics initiates Phase 1 clinical trial of ATLX-1282 and announces Series A financing extension 09.09.2025 - 09:01:06 Alchemab Therapeutics United Kingdom United States of America View original content:https://www.prnewswire.co.uk/news-releases/alchemab-therapeutics-initiates-phase-1-clinical-trial-of-atlx-1282-and-announces-series-a-financing-extension-302549526.html
